CALLAN JMB INC.
CJMBNasdaqIndustrials · Services-Business Services, NEC · NV · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | |
|---|---|---|---|
| Revenue | $5.7M | $6.6M | $13.2M |
| Operating income | −$7.0M | −$2.3M | $2.2M |
| Net income | −$8.0M | −$2.3M | $2.2M |
| Total assets | $5.8M | $5.1M | $9.7M |
| Total liabilities | $3.4M | $1.9M | $910,269 |
| Equity | $2.3M | $3.2M | $8.8M |
| EPS (diluted) | $-1.82 | $-0.87 | — |
| Shares out. | 4.4M | 3.0M | 0 |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −122.9%
- Net margin
- −139.2%
- Return on equity
- −342.2%
- Return on assets
- −137.9%
- Return on capital (ROCE)
- −161.3%
- Liabilities / assets
- 59.7%
- Debt / equity
- 1.48×
- Book value / share
- $0.52
- Revenue growth (YoY)
- −12.8%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -11.40distress
- Accruals / assets
- −59.2%clean
- Beneish M-Score
- -5.69normal
- Piotroski F-Score
- 1/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 4 warning● 1 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Bard Associates IncPassive (13G)May 13, 2026
- Ionic Ventures, LlcPassive (13G)May 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Dial GeraldDirector | Dec 30, 2025 | Buy | 10,000 | $0.76 |
| Croyle David JOfficer — Chief Medical Officer | Mar 20, 2026 | Buy | 10,195 | $1.75 |
| Croyle David JOfficer — Chief Medical Officer | Mar 6, 2026 | Buy | 14,805 | $1.76 |
| Dial GeraldDirector | Dec 30, 2025 | Buy | 461 | $1.22 |
| Williams Wayne DOfficer — CEO, Chairman and President | Dec 16, 2025 | Buy | 5,000 | $1.73 |
| Williams Wayne DOfficer — CEO, Chairman and President | Dec 11, 2025 | Buy | 62 | $1.79 |
| Williams Wayne DOfficer — CEO, Chairman and President | Dec 10, 2025 | Buy | 13,689 | $1.65 |
| Duke Liberty SmithDirector | Dec 8, 2025 | Buy | 900 | $1.56 |
| Croyle David JOfficer — Chief Medical Officer | Mar 27, 2025 | Buy | 25,000 | $4.50 |
| Williams Wayne DOfficer — CEO and President | Feb 5, 2025 | Buy | 12,500 | $4.00 |
| Croyle David JOfficer — Chief Medical Officer | Feb 5, 2025 | Buy | 24,375 | $4.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 54,372 | 1.0 | -33.8% |
| Apr 30, 2026 | 82,169 | 1.0 | -29.7% |
| Apr 15, 2026 | 116,818 | 2.1 | -11.8% |
| Mar 31, 2026 | 132,492 | 1.0 | +135.0% |
| Mar 13, 2026 | 56,378 | 1.0 | +10.2% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreementMay 27, 2026
- Delisting / listing-standard noticeApr 10, 2026
- Results of operationsMar 31, 2026
- Entered a material agreementMar 12, 2026
- Regulation FD disclosureJan 27, 2026
- Shareholder voteDec 31, 2025
- Other material eventDec 8, 2025
- Director / officer changeDec 5, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.